Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
JNJ Johnson & Johnson
- Stocks
- Healthcare
- NYSE: JNJ
Price (delayed)
$153.25
Market cap
$368.73B
P/E Ratio
16.92
Dividend/share
$5.02
EPS
$9.06
Enterprise value
$382.51B
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones
Highlights
JNJ's price to earnings (P/E) is 24% lower than its 5-year quarterly average of 22.4 and 15% lower than its last 4 quarters average of 19.8
The quick ratio has increased by 23% QoQ and by 14% YoY
The EPS has soared by 55% from the previous quarter but it has contracted by 41% YoY
Johnson & Johnson's net income has surged by 55% QoQ but it has decreased by 43% YoY
Johnson & Johnson's debt has soared by 55% YoY and by 43% from the previous quarter
Key stats
What are the main financial stats of JNJ
Market
Valuations
Earnings
Shares outstanding
2.41B
Market cap
$368.73B
Enterprise value
$382.51B
Price to earnings (P/E)
16.92
Price to book (P/B)
4.72
Price to sales (P/S)
4.13
EV/EBIT
13.96
EV/EBITDA
11.02
EV/Sales
4.28
Revenue
$89.33B
Gross profit
$61.01B
Operating income
$21.08B
Net income
$21.81B
EBIT
$27.41B
EBITDA
$34.7B
Free cash flow
$20.37B
Per share
Balance sheet
Liquidity
EPS
$9.06
EPS diluted
$8.99
Free cash flow per share
$8.46
Book value per share
$32.44
Revenue per share
$37.11
TBVPS
$46.71
Total assets
$193.67B
Total liabilities
$115.56B
Debt
$52.25B
Equity
$78.11B
Working capital
$14.65B
Debt to equity
0.67
Current ratio
1.26
Quick ratio
0.96
Net debt/EBITDA
0.4
Margins
Efficiency
Dividend
EBITDA margin
38.8%
Gross margin
68.3%
Net margin
24.4%
Operating margin
23.6%
Return on assets
11.9%
Return on equity
29.9%
Return on invested capital
44.3%
Return on capital employed
20%
Return on sales
30.7%
Dividend yield
3.28%
DPS
$5.02
Payout ratio
55.4%
JNJ stock price
How has the Johnson & Johnson stock price performed over time
Intraday
0.2%
1 week
-0.27%
1 month
-0.86%
1 year
4.27%
YTD
5.97%
QTD
-7.59%
Financial performance
How have Johnson & Johnson's revenue and profit performed over time
Revenue
$89.33B
Gross profit
$61.01B
Operating income
$21.08B
Net income
$21.81B
Gross margin
68.3%
Net margin
24.4%
Johnson & Johnson's net income has surged by 55% QoQ but it has decreased by 43% YoY
Johnson & Johnson's net margin has soared by 54% from the previous quarter but it has decreased by 46% YoY
Johnson & Johnson's operating margin has decreased by 6% YoY
JNJ's revenue is up by 4.3% year-on-year
Price vs fundamentals
How does JNJ's price correlate with its fundamentals
Growth
What is Johnson & Johnson's growth rate over time
Valuation
What is Johnson & Johnson stock price valuation
P/E
16.92
P/B
4.72
P/S
4.13
EV/EBIT
13.96
EV/EBITDA
11.02
EV/Sales
4.28
The EPS has soared by 55% from the previous quarter but it has contracted by 41% YoY
JNJ's price to earnings (P/E) is 24% lower than its 5-year quarterly average of 22.4 and 15% lower than its last 4 quarters average of 19.8
JNJ's price to book (P/B) is 19% less than its 5-year quarterly average of 5.8 and 7% less than its last 4 quarters average of 5.1
JNJ's equity is up by 12% year-on-year and by 9% since the previous quarter
The price to sales (P/S) is 17% less than the 5-year quarterly average of 5.0
JNJ's revenue is up by 4.3% year-on-year
Efficiency
How efficient is Johnson & Johnson business performance
The ROS has soared by 57% from the previous quarter but it has contracted by 38% YoY
Johnson & Johnson's return on invested capital has surged by 52% QoQ but it has decreased by 34% YoY
The return on assets has surged by 51% since the previous quarter but it has declined by 46% year-on-year
The company's return on equity has surged by 50% QoQ but it fell by 45% YoY
Dividends
What is JNJ's dividend history
DPS
$5.02
Dividend yield
3.28%
Payout ratio
55.4%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Johnson & Johnson financials performed over time
JNJ's total assets is 68% greater than its total liabilities
The quick ratio has increased by 23% QoQ and by 14% YoY
JNJ's current ratio is up by 14% since the previous quarter and by 8% year-on-year
Johnson & Johnson's debt is 33% less than its equity
Johnson & Johnson's debt has soared by 55% YoY and by 43% from the previous quarter
The company's debt to equity rose by 40% YoY and by 31% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.